As an adjunct to diet and exercise in NIDDM (type 2) patients:
- In case that the monotherapy with glimepiride or metformin do not result in adequate glycemic control
- Replacement of glimepiride and metformin combination therapy
- Metformin 500 mg
- Glimepiride 2 mg
Under 18 Years Old
Safety and effectiveness have not been established.
18 Years Old and Above
The dosage of antidiabetic drugs should be individualized based on the patient’s blood glucose levels. Generally, it should be recommended to initiate the lowest effective dose and increase the dose depending on the patient’s blood glucose levels. Adequate monitoring of blood glucose levels should be performed for this.
It should be administered once or twice per day before or with the meals. When switching from combination therapy of glimepiride plus metformin as separate tablets, GLUVAS M should be administered on the basis of dosage currently being taken.